Work

Abstract 2243: Lasofoxifene is a bone protective treatment option for estrogen receptor positive breast cancers.

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-2243

Authors: Emily Kate Zboril, David C. Boyd, Rachel K. Myrick, Nina Dashti-Gibson, Faith E. Parker, Carson Walker, Amy Olex, Chuck Harrell

Institutions: VCU Massey Comprehensive Cancer Center, Virginia Commonwealth University

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148846637

Cites:

Cited by:

Related to: